Outcomes and Management of Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion in a Primary Human Papillomavirus Screening System.
Maria A Cheung, Ciaran D McKeown, Claire M McCarthy
{"title":"Outcomes and Management of Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion in a Primary Human Papillomavirus Screening System.","authors":"Maria A Cheung, Ciaran D McKeown, Claire M McCarthy","doi":"10.5858/arpa.2024-0423-OA","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>\"Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion\" (ASC-H) cytology is uncommon (0.16%-0.43%). The reported risk of high-grade dysplasia varies hugely (12.00%-70.00%), making management challenging. Primary human papillomavirus (HPV) screening requires an updated understanding of ASC-H.</p><p><strong>Objective.—: </strong>To review ASC-H colposcopic and histologic comparators, and management outcomes, to help guide future management.</p><p><strong>Design.—: </strong>A 1-year retrospective analysis of new ASC-H-associated visits to a large colposcopy unit in Ireland in 2022 was performed.</p><p><strong>Results.—: </strong>The incidence of new ASC-H referrals was 3.63% (97 of 2672). The sensitivity of colposcopy for detection of high-grade changes (cervical intraepithelial neoplasia [CIN]2+) is 69.39% (34 of 49) and the specificity is 43.18% (19 of 44). The positive predictive value is 64.15% (34 of 53) and the negative predictive value is 37.50% (15 of 40). High-grade dysplasia was identified in 53.26% (49 of 92) and adenocarcinoma in situ in 2.17% (2 of 92) of cases. Excisional treatment was performed for 52.58% (51 of 97) and cold coagulation for 12.37% (12 of 97). The test-of-cure result was HPV negative for 84.13%. High-risk HPV and abnormal cytology was seen in 9.52% (6 of 63) of cases, thus all required a second test-of-cure smear.</p><p><strong>Conclusions.—: </strong>ASC-H with high-risk HPV has a 55.43% (51 of 92) risk of high-grade dysplasia, thus timely colposcopy and biopsy is imperative. Treatment was curative in 84.13% (53 of 63) to 96.83% (61 of 63) of cases so it is an effective management strategy. Conservative management of selected cases may be a reasonable option.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5858/arpa.2024-0423-OA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Context.—: "Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion" (ASC-H) cytology is uncommon (0.16%-0.43%). The reported risk of high-grade dysplasia varies hugely (12.00%-70.00%), making management challenging. Primary human papillomavirus (HPV) screening requires an updated understanding of ASC-H.
Objective.—: To review ASC-H colposcopic and histologic comparators, and management outcomes, to help guide future management.
Design.—: A 1-year retrospective analysis of new ASC-H-associated visits to a large colposcopy unit in Ireland in 2022 was performed.
Results.—: The incidence of new ASC-H referrals was 3.63% (97 of 2672). The sensitivity of colposcopy for detection of high-grade changes (cervical intraepithelial neoplasia [CIN]2+) is 69.39% (34 of 49) and the specificity is 43.18% (19 of 44). The positive predictive value is 64.15% (34 of 53) and the negative predictive value is 37.50% (15 of 40). High-grade dysplasia was identified in 53.26% (49 of 92) and adenocarcinoma in situ in 2.17% (2 of 92) of cases. Excisional treatment was performed for 52.58% (51 of 97) and cold coagulation for 12.37% (12 of 97). The test-of-cure result was HPV negative for 84.13%. High-risk HPV and abnormal cytology was seen in 9.52% (6 of 63) of cases, thus all required a second test-of-cure smear.
Conclusions.—: ASC-H with high-risk HPV has a 55.43% (51 of 92) risk of high-grade dysplasia, thus timely colposcopy and biopsy is imperative. Treatment was curative in 84.13% (53 of 63) to 96.83% (61 of 63) of cases so it is an effective management strategy. Conservative management of selected cases may be a reasonable option.